Axcella Health (AXLA) Gets a Hold From H.C. Wainwright
H.C. Wainwright Keeps Their Hold Rating on Axcella Health (AXLA)
Noble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
Axcella Health (AXLA) Gets a Hold From H.C. Wainwright
Axcella Health Analyst Ratings
Noble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Axcella Health (AXLA) and Baudax Bio (BXRX)
H.C. Wainwright Reaffirms Their Hold Rating on Axcella Health (AXLA)
Axcella Health Analyst Ratings
SVB Leerink Downgrades Axcella Health to Market Perform, Lowers Price Target to $2
Analysts Have Conflicting Sentiments on These Healthcare Companies: ATyr Pharma (LIFE) and Axcella Health (AXLA)
Axcella Health Analyst Ratings
SVB Securities Keeps Their Buy Rating on Axcella Health (AXLA)
Chardan Capital Maintains Buy on Axcella Health, Lowers Price Target to $5
Axcella Health Analyst Ratings
Noble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
Analysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Axcella Health (AXLA)
Wedbush Adjusts Axcella Health's Price Target to $6 From $9, Citing Stock Dilution; Outperform Rating Kept
Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday
HC Wainwright Adjusts Axcella Health's Price Target to $10 From $8, Maintains Buy Rating
No Data